Navigation Links
Charles Galea Joins dicentra as Director of Clinical Research – Business Development
Date:7/18/2020

dicentra, a leading Contract Research Organization (CRO) and global consulting firm for the life sciences and food industries, is pleased to announce that Charles Galea has joined its clinical trials division as its new Director of Clinical Research – Business Development.

Charles is an accomplished and results-driven sales executive with over 10 years of expertise in business management, account relations, client acquisition and retention, budgeting, and achieving remarkable business growth.

“Our CRO plays such an integral part in the advancement of the global nutraceutical industry and I look forward to helping our clients reach their goals, help substantiate their claims, and ultimately grow,” states Charles Galea, Director of Clinical Research.

Charles will be leading the relationship, satisfaction, and retention of clients for the clinical trial division, and will be working directly with the senior leadership team to support the continued growth of the CRO division.

“We’ve been fortunate to see our clinical trials division grow at a great rate even during a global pandemic,” states Vice President, Peter Wojewnik. “Charles will be able to aid us in our execution of clinical trials and lead the division’s continued growth and success well into the future.”

About dicentra
dicentra is a full-service Contract Research Organization (CRO) and professional consulting firm that specializes in addressing all matters related to safety, quality and compliance for all product categories in the life sciences and food industries. We evaluate, implement, and provide all the necessary support for nutraceutical and food products to gain market access and build confidence in your brand. We achieve this through our four business divisions: Life Sciences, Food Safety & Quality, Global Certifications, and Clinical Trials. Since our inception in 2002, we have completed over 18,000 projects and serviced over 1,200 companies internationally.

Our beautiful CRO clinic is located in the heart of downtown Toronto, one of the world’s most multicultural cities, boasting over 200 ethnic groups. With over 6.5 million people located right at our doorstep, we are able to recruit study subjects for clinical trials at a very fast rate, allowing our study sponsors to obtain their results sooner. For more information, visit http://www.dicentra.com.

Read the full story at https://www.prweb.com/releases/charles_galea_joins_dicentra_as_director_of_clinical_research_business_development/prweb17247627.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Charles W. Stellar Named WEDI President and CEO
2. Charleston, SC Law Firm, Rosen Hagood, Represents Biotech Workers in Obtaining $53.5 million Verdict Related to Employee Incentive Plan
3. WestEdge Launched as World Class Research Community to Help Advance Economic Future of Charleston, SC
4. PMG Research of Charleston is Participating in a Phase III Trial of an Investigational Vaccine for the Prevention of Clostridium difficile
5. Neurotech Announces Appointment of Dr. Charles Johnson as Chief Medical Officer
6. Baylor Charles A. Sammons Cancer Center at Dallas Teams with OncLive's Strategic Alliance Partnership Program
7. Benchworks Appoints Charles Laudadio, MD, MBA As Medical Director
8. Charles Marcus receives American research prize
9. Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage
10. Charles Hauser, John Vann named to PMG Research Board of Directors
11. Charles M. Lieber receives the first Nano Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 17, 2020 , ... ... and global consulting firm for the life sciences and food industries, is pleased ... new Director of Clinical Research – Business Development. , Charles is an accomplished ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
Breaking Biology Technology:
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, a ... announce that Eric Chen and Jessica Wong have joined the company’s leadership team ... respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, an ...
(Date:8/5/2020)... (PRWEB) , ... August 05, 2020 , ... Regenative Labs ... two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to ... using a syringe. The company’s solutions are the first Wharton’s jelly allograft product to ...
(Date:7/31/2020)... ... 30, 2020 , ... BioFactura, Inc. today announced a $1 ... Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense ... highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for ...
Breaking Biology News(10 mins):